e-learning
resources
Munich 2014
Monday, 08.09.2014
Tuberculosis: from diagnosis to therapy and prevention
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect
P. Escalante, T. Peikert, V. P. Van Keulen, C. L. Erskine, M. D. Behrens, L. A. Schenck, A. H. Limper (Rochester, United States Of America)
Source:
International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Session:
Tuberculosis: from diagnosis to therapy and prevention
Session type:
Poster Discussion
Number:
3064
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Escalante, T. Peikert, V. P. Van Keulen, C. L. Erskine, M. D. Behrens, L. A. Schenck, A. H. Limper (Rochester, United States Of America). Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect. Eur Respir J 2014; 44: Suppl. 58, 3064
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
ERS short guidelines on COVID-19 management
Influenza vaccination: protecting the most vulnerable
Understanding new vaccines for SARS-CoV-2 and their regulation
Related content which might interest you:
Detection of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Tuberculosis in patients receiving treatment of TNF-alpha inhibitors
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Features detection of tuberculosis in HIV-patients in the region with a high prevalence of tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Verification of pulmonary tuberculosis in HIV-infected patients with low CD4
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Features of pulmonary tuberculosis in migrants
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Predictive factors of recurrent pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Risk factors for disseminated tuberculosis
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Association of serum cytokines with pulmonary tuberculosis treatment outcomes
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Rapid monitoring of tuberculosis treatment response: A multi-centre study
Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment
Year: 2016
Lymphocytopenia in pulmonary tuberculosis: Does it have a clinical value?
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Evaluation of pulmonary TB treatment efficiency depending on polymorphism of glutathione-S-transferasexenobiotic biotransformation enzyme and on sensitivity profile
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
CD27 expression as a new tool to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
Differential characteristics of tuberculosis among immigrants
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Statin use and the risk of tuberculosis: Data from 305,142 patients
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016
Acute phase reaction in pulmonary tuberculosis during treatment
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept